Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barry J Allen

Showing results (41-50 of 55) with videos related to

Pageof 6
Sort By:
Investigative Ophthalmology & Visual Science|November 24, 2005
In vitro targeting of NG2 antigen by 213Bi-9.2.27 alpha-immunoconjugate induces cytotoxicity in human uveal melanoma cellsYong Li, Jian Wang, Syed M Abbas Rizvi, et al.
Physics in Medicine and Biology|January 11, 2008
The cytokinesis-block micronucleus assay as a biological dosimeter for targeted alpha therapyEmma Y Song, Syed M A Rizvi, Chang F Qu, et al.
Cancer Biology & Therapy|August 6, 2005
In vivo and in vitro inhibition of pancreatic cancer growth by targeted alpha therapy using 213Bi-CHX.A"-C595Chang F Qu, Yan J Songl, Syed M A Rizvi, et al.
Physics in Medicine and Biology|September 28, 2004
Targeted alpha therapy for cancerBarry J Allen, Chand Raja, Syed Rizvi, et al.
Cancer Biology & Therapy|March 19, 2008
Bismuth-213 radioimmunotherapy with C595 anti-MUC1 monoclonal antibody in an ovarian cancer ascites modelEmma Y Song, Chang F Qu, Syed M A Rizvi, et al.
Cancer Letters|June 18, 2005
Cytotoxicity of PAI2, C595 and Herceptin vectors labeled with the alpha-emitting radioisotope Bismuth-213 for ovarian cancer cell monolayers and clustersYan J Song, Chang F Qu, Syed M A Rizvi, et al.
Cancer Biology & Therapy|August 19, 2008
Preparation and testing of bevacizumab radioimmunoconjugates with Bismuth-213 and Bismuth-205/Bismuth-206Syed M Abbas Rizvi, Emma Yanjun Song, Chand Raja, et al.
Cancer Biology & Therapy|May 15, 2007
Interim analysis of toxicity and response in phase 1 trial of systemic targeted alpha therapy for metastatic melanomaChand Raja, Peter Graham, Syed M Abbas Rizvi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 4, 2009
Inhibition of micrometastatic prostate cancer cell spread in animal models by 213Bilabeled multiple targeted alpha radioimmunoconjugatesYong Li, Emma Song, Syed M Abbas Rizvi, et al.
The Prostate|September 7, 2006
Control of prostate cancer spheroid growth using 213Bi-labeled multiple targeted alpha radioimmunoconjugatesJian Wang, Syed M Abbas Rizvi, Michele C Madigan, et al.
Pageof 6

Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
Investigative Ophthalmology & Visual Science|November 24, 2005
In vitro targeting of NG2 antigen by 213Bi-9.2.27 alpha-immunoconjugate induces cytotoxicity in human uveal melanoma cellsYong Li, Jian Wang, Syed M Abbas Rizvi, et al.
Physics in Medicine and Biology|January 11, 2008
The cytokinesis-block micronucleus assay as a biological dosimeter for targeted alpha therapyEmma Y Song, Syed M A Rizvi, Chang F Qu, et al.
Cancer Biology & Therapy|August 6, 2005
In vivo and in vitro inhibition of pancreatic cancer growth by targeted alpha therapy using 213Bi-CHX.A"-C595Chang F Qu, Yan J Songl, Syed M A Rizvi, et al.
Physics in Medicine and Biology|September 28, 2004
Targeted alpha therapy for cancerBarry J Allen, Chand Raja, Syed Rizvi, et al.
Cancer Biology & Therapy|March 19, 2008
Bismuth-213 radioimmunotherapy with C595 anti-MUC1 monoclonal antibody in an ovarian cancer ascites modelEmma Y Song, Chang F Qu, Syed M A Rizvi, et al.
Cancer Letters|June 18, 2005
Cytotoxicity of PAI2, C595 and Herceptin vectors labeled with the alpha-emitting radioisotope Bismuth-213 for ovarian cancer cell monolayers and clustersYan J Song, Chang F Qu, Syed M A Rizvi, et al.
Cancer Biology & Therapy|August 19, 2008
Preparation and testing of bevacizumab radioimmunoconjugates with Bismuth-213 and Bismuth-205/Bismuth-206Syed M Abbas Rizvi, Emma Yanjun Song, Chand Raja, et al.
Cancer Biology & Therapy|May 15, 2007
Interim analysis of toxicity and response in phase 1 trial of systemic targeted alpha therapy for metastatic melanomaChand Raja, Peter Graham, Syed M Abbas Rizvi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 4, 2009
Inhibition of micrometastatic prostate cancer cell spread in animal models by 213Bilabeled multiple targeted alpha radioimmunoconjugatesYong Li, Emma Song, Syed M Abbas Rizvi, et al.
The Prostate|September 7, 2006
Control of prostate cancer spheroid growth using 213Bi-labeled multiple targeted alpha radioimmunoconjugatesJian Wang, Syed M Abbas Rizvi, Michele C Madigan, et al.
Pageof 6